By Ken Buben, President, FancyScrubs.com
The FDA last Friday has cleared the way for a new rapid diagnostic test for staph infections and their resistance to antibiotics. Being able to test quickly for this can prevent the complications from MRSA and save lives along the way. Since 1999 the number of cases of staph have increased 90%.
There are approximately 20,000 people that die every year in the USA from the MRSA. The blood infections can kill quickly if not diagnosed. It can be spread from person to person or from surfaces to person. Properly washing of hands is a must and cleaning surfaces around anyone infected is extremely important. Healthcare professionals can now wear special protective medical uniforms to prevent the spread too.
The new test, called the KeyPath MRSA/MSSA Blood Culture Test, is produced by MicroPhage Inc. and can determine whether bacteria in a patient’s positive blood culture sample are MRSA or MSSA within about five hours and does so with a 98.9 percent accuracy rate. The MicroPhage test, done through nasal screening, is expected to have significant cost and performance advantages over molecular tests like polymerase chain reaction (PCR) and other methodologies.
I hope this new test can save many lives today and in the future.